Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 926

1.

Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.

Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC.

Lancet Gastroenterol Hepatol. 2019 Aug 29. pii: S2468-1253(19)30246-8. doi: 10.1016/S2468-1253(19)30246-8. [Epub ahead of print]

PMID:
31474542
2.

What's in the pipeline for lower functional gastrointestinal disorders in the next 5 years?

Camilleri M.

Am J Physiol Gastrointest Liver Physiol. 2019 Aug 28. doi: 10.1152/ajpgi.00205.2019. [Epub ahead of print]

PMID:
31460793
3.

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.

Ballou S, McMahon C, Lee HN, Katon J, Shin A, Rangan V, Singh P, Nee J, Camilleri M, Lembo A, Iturrino J.

Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30891-2. doi: 10.1016/j.cgh.2019.08.016. [Epub ahead of print]

PMID:
31419572
4.

Evaluation of an HIV-specific rapid response service for community-based organisations in Ontario, Canada.

Camilleri M, Gogolishvili D, Giliauskas DL, Globerman J, Wilson M.

Health Res Policy Syst. 2019 Aug 14;17(1):80. doi: 10.1186/s12961-019-0476-4.

5.

Insights on Obesity in Children and Adults: Individualizing Management.

Camilleri M, Staiano A.

Trends Endocrinol Metab. 2019 Aug 5. pii: S1043-2760(19)30148-1. doi: 10.1016/j.tem.2019.07.016. [Epub ahead of print] Review.

PMID:
31395427
6.

How does one choose the appropriate pharmacotherapy for pediatric patients with functional dyspepsia?

Manini ML, Camilleri M.

Expert Opin Pharmacother. 2019 Aug 6:1-4. doi: 10.1080/14656566.2019.1650021. [Epub ahead of print] No abstract available.

PMID:
31387402
7.

Medical students on the hospital ward: what do patients really think?

Jeyaraj R, Kunnumpurath A, Soh E, Trotman R, Huckstep A, Sran H, Chang E, Newman J, Camilleri M, Dilworth JP, Fernando B.

Future Healthc J. 2019 Mar;6(Suppl 1):169. doi: 10.7861/futurehosp.6-1-s169. No abstract available.

8.

The 'Teach me' campaign - a different kind of education initiative.

Camilleri M, Chang E, Newman J, Dilworth P.

Future Healthc J. 2019 Mar;6(Suppl 1):144. doi: 10.7861/futurehosp.6-1-s144. No abstract available.

9.

Etiopathogenetic Mechanisms in Diverticular Disease of the Colon.

Camilleri M, Sandler RS, Peery AF.

Cell Mol Gastroenterol Hepatol. 2019 Jul 25. pii: S2352-345X(19)30095-5. doi: 10.1016/j.jcmgh.2019.07.007. [Epub ahead of print] Review.

10.

Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms.

Chakraborty S, Desai A, Halland M, Burton D, Camilleri M, Zinsmeister AR, Bharucha AE.

Neurogastroenterol Motil. 2019 Jul 21:e13686. doi: 10.1111/nmo.13686. [Epub ahead of print]

PMID:
31328363
11.

Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.

Wang XJ, Camilleri M, Vanner S, Tuck C.

Aliment Pharmacol Ther. 2019 Sep;50(5):517-529. doi: 10.1111/apt.15419. Epub 2019 Jul 15. Review.

PMID:
31309595
12.

Microbiome: In Search of Mechanistic Information and Relevance.

Camilleri M, Vakil N.

Am J Gastroenterol. 2019 Jul;114(7):1014-1016. doi: 10.14309/ajg.0000000000000306. No abstract available.

PMID:
31211707
13.

Is reattaching an open intravenous fluid bag ever justified?

Camilleri M, Carle C.

Br J Hosp Med (Lond). 2019 Jun 2;80(6):358. doi: 10.12968/hmed.2019.80.6.358. No abstract available.

PMID:
31180785
14.

Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant.

Vijayvargiya P, Gonsalves W, Burton D, Hogan WJ, Miceli T, Rossini W, Taylor A, Lueke A, Donato L, Camilleri M.

Bone Marrow Transplant. 2019 May 31. doi: 10.1038/s41409-019-0581-6. [Epub ahead of print]

PMID:
31148601
15.

Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations.

Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD.

Am J Physiol Gastrointest Liver Physiol. 2019 Jul 1;317(1):G17-G39. doi: 10.1152/ajpgi.00063.2019. Epub 2019 May 24.

16.

Full-thickness evaluation from endoscopic rectal sampling: an important first step in tissue diagnosis of colonic dysmotility.

Maselli D, Camilleri M.

Gastrointest Endosc. 2019 Jun;89(6):1248-1250. doi: 10.1016/j.gie.2019.01.028. No abstract available.

PMID:
31104753
17.

Use of prucalopride in adults with chronic idiopathic constipation.

Vijayvargiya P, Camilleri M.

Expert Rev Clin Pharmacol. 2019 Jul;12(7):579-589. doi: 10.1080/17512433.2019.1620104. Epub 2019 May 23. Review.

PMID:
31096799
18.

Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I.

Clin Transl Gastroenterol. 2019 May 22;10(5):1. doi: 10.14309/ctg.0000000000000051. No abstract available.

PMID:
31082857
19.

Leaky gut: mechanisms, measurement and clinical implications in humans.

Camilleri M.

Gut. 2019 Aug;68(8):1516-1526. doi: 10.1136/gutjnl-2019-318427. Epub 2019 May 10. Review.

PMID:
31076401
20.

Glucagon-Like Peptide-1 Secretion in Pre-Diabetes Revisited.

Smushkin G, Sathananthan A, Dalla Man C, Camilleri M, Cobelli C, Rizza RA, Vella A.

J Clin Endocrinol Metab. 2019 May 10. pii: jc.2019-00904. doi: 10.1210/jc.2019-00904. [Epub ahead of print] No abstract available.

PMID:
31074786
21.

A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.

Brenner DM, Hu Y, Datto C, Creanga D, Camilleri M.

Am J Gastroenterol. 2019 Jun;114(6):954-963. doi: 10.14309/ajg.0000000000000229.

22.

Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea.

Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I.

Clin Transl Gastroenterol. 2019 Apr 26. doi: 10.14309/ctg.0000000000000019. [Epub ahead of print]

PMID:
31045594
23.

Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.

Saffouri GB, Shields-Cutler RR, Chen J, Yang Y, Lekatz HR, Hale VL, Cho JM, Battaglioli EJ, Bhattarai Y, Thompson KJ, Kalari KK, Behera G, Berry JC, Peters SA, Patel R, Schuetz AN, Faith JJ, Camilleri M, Sonnenburg JL, Farrugia G, Swann JR, Grover M, Knights D, Kashyap PC.

Nat Commun. 2019 May 1;10(1):2012. doi: 10.1038/s41467-019-09964-7.

24.

Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea.

Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00019. doi: 10.14309/ctg.0000000000000019.

PMID:
31033595
25.

Editorial: effects of vildagliptin on GLP-1 levels, gastric motor function and food intake.

Camilleri M.

Aliment Pharmacol Ther. 2019 May;49(10):1362-1363. doi: 10.1111/apt.15206. No abstract available.

PMID:
31016769
26.

Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.

Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC.

Gut. 2019 Apr 17. pii: gutjnl-2018-318160. doi: 10.1136/gutjnl-2018-318160. [Epub ahead of print]

PMID:
30996042
27.

Changes in Time of Gastric Emptying After Surgical and Endoscopic Bariatrics and Weight Loss: A Systematic Review and Meta-Analysis.

Vargas EJ, Bazerbachi F, Calderon G, Prokop LJ, Gomez V, Murad MH, Acosta A, Camilleri M, Abu Dayyeh BK.

Clin Gastroenterol Hepatol. 2019 Apr 4. pii: S1542-3565(19)30363-5. doi: 10.1016/j.cgh.2019.03.047. [Epub ahead of print]

PMID:
30954712
28.

Chronic Megacolon Presenting in Adolescents or Adults: Clinical Manifestations, Diagnosis, and Genetic Associations.

Wang XJ, Camilleri M.

Dig Dis Sci. 2019 Oct;64(10):2750-2756. doi: 10.1007/s10620-019-05605-7. Epub 2019 Apr 5. Review.

PMID:
30953226
29.

Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.

Wang M, Lehman JS, Camilleri MJ, Drage LA, Wieland CN.

J Am Acad Dermatol. 2019 Aug;81(2):472-479. doi: 10.1016/j.jaad.2019.03.062. Epub 2019 Mar 28.

PMID:
30928465
30.

Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy.

Wang XJ, Camilleri M.

World J Gastroenterol. 2019 Mar 14;25(10):1185-1196. doi: 10.3748/wjg.v25.i10.1185. Review.

31.

Gastric accommodation measurements by single photon emission computed tomography and two-dimensional scintigraphy in diabetic patients with upper gastrointestinal symptoms.

Chedid V, Halawi H, Brandler J, Burton D, Camilleri M.

Neurogastroenterol Motil. 2019 Jun;31(6):e13581. doi: 10.1111/nmo.13581. Epub 2019 Mar 13.

PMID:
30868676
32.

Current Practice in the Diagnosis of Bile Acid Diarrhea.

Vijayvargiya P, Camilleri M.

Gastroenterology. 2019 Apr;156(5):1233-1238. doi: 10.1053/j.gastro.2018.11.069. Epub 2019 Mar 5. No abstract available.

PMID:
30844373
33.

Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.

Nakajima A, Taniguchi S, Kurosu S, Gillberg PG, Mattsson JP, Camilleri M.

Neurogastroenterol Motil. 2019 May;31(5):e13571. doi: 10.1111/nmo.13571. Epub 2019 Feb 21.

34.

Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.

Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ.

Aliment Pharmacol Ther. 2019 Mar;49(6):744-758. doi: 10.1111/apt.15106. Epub 2019 Feb 10.

PMID:
30740753
35.

The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.

Revicki DA, Speck RM, Lavoie S, Puelles J, Kuo B, Camilleri M, Almansa C, Parkman HP.

Neurogastroenterol Motil. 2019 Apr;31(4):e13553. doi: 10.1111/nmo.13553. Epub 2019 Feb 7.

PMID:
30734412
36.

Personalized management in functional gastrointestinal disorders based on genomics: hope at last or just feigned praise?

Wang XJI, Camilleri M.

Therap Adv Gastroenterol. 2019 Jan 23;12:1756283X18822791. doi: 10.1177/1756283X18822791. eCollection 2019. No abstract available.

37.

Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.

Vijayvargiya P, Camilleri M, Chedid V, Mandawat A, Erwin PJ, Murad MH.

Gastroenterology. 2019 May;156(6):1650-1660. doi: 10.1053/j.gastro.2019.01.249. Epub 2019 Jan 31.

PMID:
30711628
38.

Familial chronic megacolon presenting in childhood or adulthood: Seeking the presumed gene association.

Camilleri M, Wieben E, Eckert D, Carlson P, Hurley O'Dwyer R, Gibbons D, Acosta A, Klee EW.

Neurogastroenterol Motil. 2019 Apr;31(4):e13550. doi: 10.1111/nmo.13550. Epub 2019 Jan 20.

PMID:
30663199
39.

Reply.

Camilleri M.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):214. doi: 10.1016/j.cgh.2018.09.048. No abstract available.

PMID:
30558895
40.

The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.

Revicki DA, Lavoie S, Speck RM, Puelles J, Kuo B, Camilleri M, Almansa C, Parkman HP.

J Patient Rep Outcomes. 2018 Dec 13;2(1):61. doi: 10.1186/s41687-018-0081-2.

41.

Management Options for Irritable Bowel Syndrome.

Camilleri M.

Mayo Clin Proc. 2018 Dec;93(12):1858-1872. doi: 10.1016/j.mayocp.2018.04.032. Review.

PMID:
30522596
42.

Current and future impact of clinical gastrointestinal research on patient care in diabetes mellitus.

Koch TR, Shope TR, Camilleri M.

World J Diabetes. 2018 Nov 15;9(11):180-189. doi: 10.4239/wjd.v9.i11.180.

43.

Audit of the diagnosis of rectal evacuation disorders in chronic constipation.

Chedid V, Vijayvargiya P, Halawi H, Park SY, Camilleri M.

Neurogastroenterol Motil. 2019 Jan;31(1):e13510. doi: 10.1111/nmo.13510. Epub 2018 Nov 13.

PMID:
30426597
44.

Gastrointestinal hormones and regulation of gastric emptying.

Camilleri M.

Curr Opin Endocrinol Diabetes Obes. 2019 Feb;26(1):3-10. doi: 10.1097/MED.0000000000000448.

PMID:
30418188
45.

Evaluation of Patients with Suspected Gastroparesis.

Szarka LA, Camilleri M.

Gastrointest Endosc Clin N Am. 2019 Jan;29(1):39-54. doi: 10.1016/j.giec.2018.08.004. Epub 2018 Sep 11. Review.

PMID:
30396527
46.

Gastroparesis.

Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, Low PA, Park SY, Parkman HP, Stanghellini V.

Nat Rev Dis Primers. 2018 Nov 1;4(1):41. doi: 10.1038/s41572-018-0038-z. Review.

47.

GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist.

Chakraborty S, Halland M, Burton D, Desai A, Neja B, Low P, Singer W, Camilleri M, Zinsmeister AR, Bharucha AE.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):1967-1977. doi: 10.1210/jc.2018-01623.

PMID:
30358871
48.

Upper-Rim Monofunctionalisation in the Synthesis of Triazole- and Disulfide-Linked Multicalix[4]- and -[6]arenes.

Gardiner WH, Camilleri M, Martinez-Lozano LA, Bew SP, Stephenson GR.

Chemistry. 2018 Dec 17;24(71):19089-19097. doi: 10.1002/chem.201804755. Epub 2018 Nov 26.

PMID:
30325070
49.

New developments in the treatment of gastroparesis and functional dyspepsia.

Tack J, Camilleri M.

Curr Opin Pharmacol. 2018 Dec;43:111-117. doi: 10.1016/j.coph.2018.08.015. Epub 2018 Sep 21. Review.

PMID:
30245474
50.

Elobixibat for the treatment of constipation.

Chedid V, Vijayvargiya P, Camilleri M.

Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):951-960. doi: 10.1080/17474124.2018.1522248. Epub 2018 Sep 20.

PMID:
30204504

Supplemental Content

Loading ...
Support Center